New VHD Post-ACC.19 Content

Cardiology Magazine Image

Check out the ACC.19 Meeting Coverage Page for post-meeting content on valvular heart disease (VHD) to reinforce the teaching points and education presented during ACC.19.

In a recent expert analysis, Ahmad Masri, MD, et al., review and discuss key findings from the hottest trials on VHD, including PARTNER 3, Evolut Low Risk, COAPT-QoL, POET and others. Read more.

View additional learning pathway presentations in iScience, the ACC.19 Meeting on Demand Program.

Stay tuned as more content will be added to the ACC.19 Meeting Coverage Page.